Welcome : Guest

Aurinia Pharmaceuticals, Inc. (Canada) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Aurinia Pharmaceuticals, Inc., which is principally involved in Clinical-Stage Pharmaceuticals Business. Illustrated with 13 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-63796
Price: $650
Company Type: Public
Pages: 14
Date: November 2016
Market Data Tables: 13

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Aurinia Pharmaceuticals, Inc.’s Sales by Geographic Region Worldwide (2014-2015) in Percentage for Canada, and China......2
Table 2: Aurinia Pharmaceuticals, Inc.’s Sales by Geographic Region Worldwide (2014) in Percentage for Canada and China......3
Systemic Lupus Erythematosus with Benlysta......4
Table 3: Systemic Lupus Erythematosus with Benlysta Market by Category in the US (2015) - Percentage Share Breakdown by Value for Mild Systemic Lupus Erythematosus (excluded in target population), Moderate Systemic Lupus Erythematosus, and Severe Systemic Lupus Erythematosus......4
End-Stage Renal Disease (ESRD)......5
Table 4: End-Stage Renal Disease (ESRD) Market by Cause in China (2015) - Percentage Share Breakdown by Value for Diabetic Nephropathy, Glomerular Disease, Hypertension Caused Renal Disease and Others......5
Table 5: End-Stage Renal Disease (ESRD) Cases by Age Group in the US (2015) - Percentage Share Breakdown for 45-64, 65-74, 75+, and Others......6
Table 6: End-Stage Renal Disease (ESRD) Cases by Diagnosis in the US (2015) - Percentage Share Breakdown by Value for Cystic Kidney, Diabetes, Glomerulonephritis, Hypertension, and Others......7
Kidney Disease Drugs......8
Table 7: Traditional Chinese Medicine (TCM) Market for Kidney Ailments by Drug in China (2015) - Percentage Share Breakdown by Value Sales for Ambrette Capsule, Haikunshenxi Capsule, Shenyankangfu Tablet, Uremic Clearance Granule, Yinhuamiyangling and Others......8
Table 8: Kidney Disease Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp and Others......9
Table 9: Dialysis Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp, EPO alfa/beta biosimilars and Others......10
Table 10: Hemodialysis Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp, Epogen, and Others (Mircera)......11
Table 11: Chronic Kidney Disease Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp and Others......12
Table 12: Peritoneal Dialysis Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp, Epogen, and Others (Includes Mircera)......13
Table 13: New Patients with Kidney Failure by Cause in the US (2015) - Percentage Share Breakdown by Volume for Diabetes, High Blood Pressure and Others......14